ORTEXORTEX News
Tracking DBD? Get live short interest, options flow, and signals on ORTEX.Sign up free →
DB
Earnings PreviewDBD

DBD Heads Into Q3 Print With Bears Positioned But Not Crowded

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 27 Oct 2026, 04:03

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Diebold Nixdorf reports Q3 results on October 28 with short sellers meaningfully present but the lending market signalling little urgency on either side.

Short interest has climbed to 9.5% of the free float, up roughly 8% over the past month as positions accumulated steadily through October. That is a level worth watching, but the borrow market tells a more relaxed story. Availability is running near 296%, meaning shares to lend comfortably outnumber shares already borrowed. Borrowing costs are low at 0.67% annualised and have eased 22% over the past week. The ORTEX short score sits at 66.8, broadly stable across the past ten sessions, pointing to elevated but not extreme bearish conviction. Options positioning is mildly more cautious than usual: the put/call ratio is 0.84, about half a standard deviation above its 20-day average of 0.63, but well inside the range the stock has seen over the past year. The stock has gained roughly 10% over the past month to close at $68.82, pulling back just 0.5% on Monday.

The bull and bear cases heading into the print pull in sharply different directions. Bulls point to the company's own 2026 EBITDA guidance of $510M to $535M, expected free cash flow conversion above 50% of EBITDA, and net leverage of only 1.2x, giving management room for buybacks and refinancing. The Retail segment's 26% year-over-year revenue jump last quarter, driven by ePOS and AI-powered SmartVision deployments, adds a growth angle beyond the core ATM franchise. Wedbush reiterated its Outperform rating and $100 target on October 15, keeping the bull flag flying close to the print. Bears focus on structural pressure: ATM demand is declining, competition is intensifying, and the stock trades with thin daily liquidity of roughly $7M, while debtholders controlling around 60% of common shares create a persistent overhang. The mean analyst price target of $100, set against a current price of $68.82, implies meaningful upside on paper, though the consensus data dates to May and that gap deserves some caution.

Ownership adds one layer worth noting. Capital Research holds 34.9% of shares, an unusually concentrated anchor position. BlackRock added over 2.5 million shares in the quarter ending September 30, lifting its stake to 13.4%. Those two moves together account for nearly half the company's float and reduce the pool available to drive sharp price swings in either direction, which may partly explain why the stock has been less volatile than correlated peers despite a meaningful short position.

The October 28 print will therefore test whether the Retail recovery has enough momentum to offset any softness in Banking, and whether management's margin and cash-flow targets remain intact after a quarter shaped by tariff and FX noise.

Stocks in this article

See the live data behind this article on ORTEX.

Open DBD on ORTEX →

How this article was generated

Generated
27 Oct 2026, 04:47
Data as of
27 Oct 2026, 04:03
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.